Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Recruiting

    2 1
    Investigated Drugs:
    Czechia Denmark Germany Hungary Italy The Netherlands +2
  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Italy Poland Portugal Spain
  • Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Poland Spain
  • Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1
    Investigated Drugs:
    Poland Spain Sweden
  • Study on Atorvastatin for Preventing Chronic Migraine in Adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway
  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway
  • Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Recruiting

    3 1
    Investigated Drugs:
    Belgium Denmark France Hungary Italy The Netherlands +4
  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark France Hungary Italy The Netherlands +5
  • Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

    Recruiting

    3 1 1
    Investigated Diseases:
    Austria Czechia Denmark France Germany Italy +3
  • A study to evaluate the safety and effectiveness of omalizumab in adults with episodic migraine

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway